text:
11 Jul. 2013 | Comments (8) Share Follow @Conferenceboard
Losing hurts – especially when it's the other person who decides to move on. "Regretted turnover" is a metric that some companies use to track how many employees choose on their own to leave. Turnover is costly in general, but losing top talent can also cause significant, even irreparable damage to your business.
The term top talent describes people whose performance and behaviors are consistently exceptional and aligned with the company's values. They are agile and adaptable, and they are continuous learners and adept problem solvers. They're scarce, impossible to reproduce, and capable of creating significantly more value than other employees. They are people who customers pay a premium to do business with and who other employees imitate and aspire to work with.
While most employees are capable of exceptional performance some of the time, top talent performs exceptionally most of the time. They are aggressively pursued by recruiters representing other companies. Their capabilities are generally transferable across traditional boundaries, such as industries or geographies, so they can leave at any time to join just about any company they wish.
Addressing the following threats and applying the strategies below can help you improve your position in the talent retention war.
Retention Threats:
Even the best companies will lose top talent – in fact they're at greater risk because other companies target their people. Lessening the following threats will help you retain top talent.
1) Bad ka"HR"ma – Poorly executed people practices may come back to bite companies that haven't been doing right by their people. This isn't a swipe at HR practitioners – it's up to business leaders to make processes like talent acquisition, performance management and leadership development work as intended. Companies kicked lots of talent to the curb when they downsized. While some companies handled layoffs well, others tripped and failed to treat human beings with respect and dignity. Some companies even carried their lousy treatment of people over into the hiring process, mistreating wishful candidates who were desperate for work, in the process.
2) Guerilla warfare – As the demand and competition for top talent increase, the tactics used by your competitors and their agents to acquire top talent will get more creative and nastier. Top talent will continue to get heavily solicited by recruiters. Plus, people are more networked than ever and many jobs are actually filled through networking. What was once six degrees of separation has been greatly reduced thanks to networking sites like LinkedIn. Such sites provide employees with direct access to new opportunities and they let recruiters identify and directly contact so-called passive candidates who aren't actively looking for another job.
Retention Strategies:
Consider applying the following strategies to improve your position in the war:
1) Identify and notify – Identify people you cannot afford to lose and tell them that they're highly valued*. And tell them specifically why they are so well regarded. Make sure they receive continuous assessment, feedback and coaching. Check that their current job is still developing them. Recognize and reward them both publicly and personally. Accelerate their development by exposing them to a diverse mix of assignment and experiences that: give them a big picture view, let them contribute innovative ideas, and allow interaction with company executives. Finally, see to it that their compensation and long-term incentives reflect their value to the business.
* Don't use a label like top talent unless the criteria have been well-defined, you are very confident in your leaders' assessment and communication abilities, and the senior leadership team has thoroughly reviewed, vetted, and calibrated them.
2) Produce alumni advocates – Help employees manage their own development and careers and you'll get more productive and engaged employees in return. Employees are going to leave eventually for one reason or another, and there's an added benefit to treating people right (as if those mentioned aren't enough). If they feel they were treated well, then alumni will be more likely to recommend your company as a great place to work and grow. Remember that we are living in a hyper-networked world, and word of mouth spreads far and fast.
Bottom line – It's only going to get harder and more expensive for you to hire and keep top talent. They have more choices (and temptations) to leave than ever before. It is no longer good enough to simply say that "people are our most important asset". They want tangible proof. Therefore, your talent management strategy has to be well-crafted, communicated, and acted on. If it isn't, then you'll have a hard time making the case for top talent to stay.
So, how are you faring in the talent retention war? What will you do to strengthen your position?
View our complete listing of Talent Management blogs.
8 Comment(s) Comment Policy
Steve Hart 0 people like this 15 Jul. 2013 11:36 AM
David certainly hits the mark in this blog. It reminds me that leaders have a very big responsibility to create an environment for their staff that does honor to their human spirit. More leaders need this message and have to understand that the key to talent retention is really paying attention to them.
Ed Henkler 0 people like this 26 Aug. 2013 09:31 PM
I like the second strategy and while I think there is definite value in devoting some extra attention to your top talent, I think it is more important to understand their dreams. If their dream is to become a senior leader of your company, then you can certainly invest and create opportunities. If their dream is to become a globe-trotting consultant, you may never keep them but can absolutely create an alumni advocate.
Great article!
Karen DiNunzio 0 people like this 27 Aug. 2013 07:52 AM
You make many important points, David.
Good employees need to be treated well
regardless of economic times. Executives who understand how to treat people well win
the "talent war".
Mark Norland 0 people like this 04 Sep. 2013 07:43 PM
Another great article, David! Your candor and insight hit the mark in so many ways. One of the things that really resonated with me was your sage caution re: not over-defining "top talent." The criteria will always be dynamic and as you point out, top performers are typically agile and adaptable - by definition, they themselves are dynamic. Also really liked your points about networking and self-directed learning!


text:
Poster Board
ECCO2017: European Cancer Congress
27 January 2017
Amsterdam, The Netherlands
Showing 368 posters
159. Factors affecting survival in triple negative breast cancer Egyptian patients
160. Direct linear correlation between serum vascular endothelial growth factor (VEGF) and Ki-67 (MIB-1 rate) in women with pT1-2 breast cancer
162. A randomized controlled lifestyle intervention in BRCA mutation carriers
164. Evaluation of prognostic and predictive value of novel markers (NF-kB and ODC) alone and in combination with other markers for patients with breast cancer
165. Is Indian breast cancer biology different from its western counterpart: A study of clinical & pathological correlation of biomolecular sub-typing of breast cancer in Northern India
166. Triple Negative Breast Cancer in Indian population: An analysis from tertiary cancer center in India
168. Adjuvant breast cancer treatments induce changes in homoarginine levels
169. Correlation between BI-RADS classification and histopathological findings of breast lesions in Albanian women
170. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience
173. Low cause-specific mortality in women treated for ductal carcinoma in situ of the breast
174. Investigation of the role of VEGF-A +936C>T and -634 G>C as prognostic and risk factors in breast cancer patients
175. Burden of early and advanced breast cancer in the Netherlands
176. Ethnic disparities in breast cancer survival in New Zealand: Why do Maori fare poorly?
177. Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
178. New biomarker of tumor progression of breast cancer - survivin gene expression in the primary tumor and circulating tumor cells
180. Quality of life in elderly patients with breast cancer after mastectomy evaluated using the short form of the Medical Outcomes Study questionnaire (MOS-SF-36)
181. Proliferative Score in Predicting Recurrence Risk of Breast cancer
182. Gremlin 1 expression correlates with prognostic features and survival in breast carcinoma
187. BRCA1/2 mutation in breast cancer: Biological aspects, patterns of care and impact on outcome in a monoinstitutional cohort
191. Clinicoepidemiological study of breast cancer patients at Clinical Oncology Department Ain Shams University: Five years retrospective study
192. The numbers of Foxp3 positive cells in simultaneous bilateral ER-positive and HER2-negative breast cancer
193. Evaluation of Her-2/neu receptor status and its association with age, menopausal status, histopathological features and ER/PR status in operable carcinoma breast
194. Which one is the best for estrogen receptor positive and triple negative breast cancers; hyperthermia before radiotherapy or after?
195. Which one is the best for breast cancer; tamoxifen plus hyperthermia or tamoxifen plus radiotherapy?
196. Accuracy of ultrasound scan guided node biopsy in pre-operative diagnosis of metastatic axillary lymphadenopathy in breast cancer
197. Does combination of neoadjuvant chemotherapy and therapeutic mammoplasty reduces the need for mastectomy?
199. A decision aid for curatively treated breast cancer patients to effectively individualize the aftercare, improve shared decision making, and reduce costs
200. 18FDG PET-CT - SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma
205. Are community detected cancers more biologically similar to screen detected or interval breast cancers and how is this reflected in survival?
206. Abnormalities in miRNAome contribute to epithelial-mesenchymal transition of breast cancer cells
208. Classifying variants in the CHEK2 gene: The importance of collaboration
211. Dosimetric advantage of Deep Inspiration Breath Hold in left breast radiotherapy: Comparative analysis with free breathing
213. Magnetic resonance imaging in the evaluation of tumor node in breast cancer after neoadjuvant treatment
214. The role of post-mastectomy radiotherapy (PMRT) and prognostic factors of locoregional recurrence
215. Hypofractionated radiotherapy after conservative surgery in breast cancer patients: A phase i-ii trial (mara-1)
216. Effect of radiotherapy for breast cancer on the prognosis of a subsequent myocardial infarction
ePoster223. Usefulness of pre-operative axillary ultrasound investigation, ultrasound-guided fine-needle aspiration biopsy and/or intra-operative imprint cytological investigation in patients undergoing mastectomy because of invasive lobular breast carcinoma
224. Audit on cavity margins for breast conserving surgery at a District General Hospital
228. Feasibility of extended sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer patients
230. Ipsilateral breast recurrence after breast-conserving surgery in young Japanese patients with breast cancer
231. Preferences of women in deciding on treatment for low-grade Ductal Carcinoma In Situ (DCIS)
232. Attitudes and beliefs of breast cancer patients toward their disease in urban South Africa: A cross-sectional descriptive study
233. Correlation of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) to lymph node (SLN) involvement in breast cancer
234. Distress among women taking part in surgical continuity of care for breast cancer: A mixed methods study
235. Patient nutritional status: Serum albumin levels a predictive indicator of survival in patients with metastatic breast cancer
ePoster237. Breast reconstruction using modified inferior dermal flap, implant, and nipple areola complex repositioning technique. Experience at MISR Cancer Center
239. Assessment of EpCAM intensity of expression and outcome in breast carcinoma neoadjuvant chemotherapy treated patients
240. The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
242. Predictive factors for recurrence following neoadjuvant chemotherapy and definitive surgery for stage II and III breast cancer: A retrospective review
243. Pembrolizumab for metastatic triple-negative breast cancer (mTNBC): long-lasting responses in the phase Ib KEYNOTE-012 study
245. Role of patient organizations in the fight against cancer - Mamma HELP, its projects, activities and experience
246. Treatment with eribulin mesilate could suppress epithelial-mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer. -Preliminary Report of a Prospective Study-
248. Interplay of MDM2 and PSMA modulates the secretion of the MMPs through AKT phosphorylation in breast cancer cells
249. Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis
251. The efficacy and tolerability of Eribulin for advanced or metastatic breast cancer – A case series from the Norfolk and Norwich University Hospital NHS Foundation Trust, United Kingdom
252. Safety and effectiveness of anti-HER2 therapy in patients with advanced metastatic tissue HER2-negative breast cancer with elevated serum HER2 and/or HER2 overexpressing circulating tumor cells
253. A pharmacokinetics (PK) bioequivalence trial of proposed trastuzumab biosimilar, Myl-1401O (A) vs EU-Trastuzumab (B) and US-Trastuzumab (C)
254. A pharmacokinetics and pharmacodynamics equivalence trial of proposed Pegfilgrastim biosimilar, MYL-1401H vs EU Neulasta® and US Neulasta®
255. Heritage: A randomized double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin
256. Phase 3 efficacy and safety trial of proposed Pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactis of chemotherapy-induced neutropenia
257. Patterns of response to endocrine therapy in metastatic breast cancer
258. Impact of neoadjuvant chemotherapy on breast cancer survival: A systematic review and meta-analysis
259. Total preoperative NACT vs sandwich NACT in breast cancer patients: Systematic review and meta-analysis
262. Lipegfilgrastim is cost-effective in reducing chemotherapy-induced neutropenia in breast cancer patients
263. Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx)
315. Prediction of facial nerve position in Large Vestibular Schwannomas using Diffusion Tensor Imaging (DTI) tractography and its intra-operative correlation
318. FAT1 knockdown led to reduce EMT and stemness genes expression in hypoxic glioma
322. Comparing quality of glioblastoma resections between care teams
323. Management of symptomatic paediatric vertebral haemangiomas by an innovative technique
324. Surgical outcome of microsurgical excision of brain and spinal cord cavernomas: Our 13 year single center experience
328. Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: A single-institution experience
330. Fotemustina as a third line treatment of high-grade glioma
433. The results of neoadjuvant chemoradiation therapy in combined treatment of rectal cancer
435. A national survey on the management of liver metastases from colorectal cancer (CRC): comparison of perspectives and expectations among oncologists and hepatobiliary surgeons across Canada
436. Preoperative hyperfractionated concurent radiochemotherapy for locally advanced rectal cancers: A phase II clinical study
437. The role of Multidisciplinary team discussions in clinical practice: A population-based assessment of rectal cancer patients in Catalonia
439. Incidence of Colorectal cancer in Sri Lanka: Analysis of the cancer registry data and comparison with other South Asian populations
440. Outcomes of preoperative chemoradiotherapy for rectal cancer with lateral pelvic lymph node metastasis
441. Chemotherapy does not impair parenchymal sparing surgery to treat colorectal liver metastases
442. Near Infra Red Fluorescence Imaging after intraoperative injection of Indocyanine Green to improve the staging during cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: Results of a pilot prospective study (NCT02032485)
443. Prospective evaluation of the impact of multidisciplinary meetings on the decision making process in gastro-intestinal oncology
444. Evaluating the scientific basis of quality indicators in colorectal cancer care: results of a systematic review
445. Clinical impact of MRI vs computed tomography in the diagnostic work-up of colon cancer patients
446. Long-term follow-up features on rectal MRI during a 'watch-and-wait' approach in clinical complete responders after chemoradiotherapy: an update of 140 patients
447. Safety of Bevacizumab versus no-Bevacizumab treatment used on metastatic colorectal cancer: a systematic review and metanalysis
448. The Prospective Dutch ColoRectal Cancer cohort (PLCRC) – a prospective nationwide observational cohort study
449. Ways to improve long-term results of combined treatment of patients with colorectal cancer liver metastases
450. The International Watch and Wait Database (IWWD) for rectal cancer, an update
451. Vitamin D receptor and calcium sensing receptor polymorphisms and colorectal cancer survival in Newfoundland population
452. Tumor hypoxia in colorectal cancer evaluated by 18F-Fluoromisonidazol PET/CT
453. Examining the direct and indirect effects of socioeconomic status (SES) on colorectal cancer risk using structural equation modeling
455. Unique gene expression signature of cancer initiating cells in colorectal cancer
456. Radiomics signature of primary diffusion MR for treatment response prediction in rectal carcinoma
458. Updated prognostic models for local recurrence, distant metastases and overall survival in a pooled dataset of 3770 rectal cancer patients
459. Predictive value of [18F]FDG PET/CT in patients affected by rectal cancer: correlation with tumour characteristics, treatment response and survival
463. 5-aminolevulinic acid-mediated fluorescence in colon cancer surgery: a histopathological analysis of fluorescent and non-fluorescent tumours
466. Analysis of factors affecting survival in patients with lung metastases from colorectal cancer who underwent VATS-assisted surgical excision
468. Evaluation of weight status during the time between ileostomy formation and closure in individuals who were operated due to rectal cancer
469. Contributions of patient-, tumor-, and treatment-related factors to the patients' outcome after curative liver resection among Egyptian patients with metastatic colorectal tumor
471. Long-term results of total mesorectal excision for rectal cancer: Prospective single-center study
474. Prediction and prevention of liver failure after major liver resections for liver metastases of colorectal cancer: The role of functional tests
476. Pressurized Intraperitoneal Aerosole Chemotherapy (PIPAC) for unresectable peritoneal carcinomatosis: The French experience
479. Prognostic value of pre-operative neutrophil lymphocyte ratio in predicting patient survival in lower gastrointestinal malignancy
480. Reassessing, revisiting and redoing incomplete lymph nodal clearance in colon cancer: Our experience
481. ONCOPRE: a new chemotherapy benefit prediction algorithm to assist with treatment decision making
482. Simultaneous, but not consecutive combination with folinate salts potentiates 5-fluoruracil antitumor activity in vitro
483. CXCR4 promotes adhesion capacity and activates the AKT signalling pathway in colorectal cancer cells
484. Evaluation of guideline adherence in colorectal cancer treatment in The Netherlands: a survey among medical oncologists by the Dutch Colorectal Cancer Group (DCCG)
485. Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients
486. Perioperative systemic therapy for colorectal peritoneal metastases: sufficient evidence for its widespread use? A critical systematic review
ePoster487. A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: Results of the phase I study
488. Evaluating the potential of Dabigatran etexilate in treatment of metastatic colon cancer
489. Modulation of platelet levels by an anti-IL-1α antibody (MABp1) in advanced colorectal cancer patients
490. Do microRNAs dictate response to drugs in colon cancer patients ?
491. ISO-005; An open-label, multiple-site, dose cohort, phase I/II study in patients with Stage IV Colorectal cancer
598. Incidence of gastric cancer in Sri Lanka: Analysis of the cancer registry data and comparison with other South Asian populations
599. Types and patterns of gastro intestinal polyps encountered in oesophago-gastro-duodenoscopy at a tertiary care center
600. Approaches for optimal choice in treatment of gastric cancer with liver metastases
601. Serum tumor markers carcinoma antigen (CA) 72-4 versus carcinoembryonic antigen (CEA) in patients with early stage (IA-IB) gastric cancer
602. The epidemiological study of upper gastrointestinal cancer screening in rural areas in Sichuan,China
603. Potential implication of SOCS-4 in pancreatic cancer development
604. The impact of histological subtype on the prognosis of oesophageal adenocarcinoma
608. Clinical significance of D2-40 and CD31, lymphatic and blood vessel invasion markers, in gastric cancer
609. Preoperative assessment of operability in pancreatic and periampullary carcinoma based on multislice computerized tomography and endoscopic ultrasonography
610. Prognostic impact of preoperative serum CA 19-9 level in pancreatic cancer: A pooled analysis
612. To assess the proportion and clinicoradiological profile of gall bladder carcinoma diagnosed in routine histopathological examinations of post cholecystectomy gall bladder(GB) specimen operated for benign GB disease
613. Clinical significance of expression of Cripto-1 in patients of squamous cell carcinoma of oropharynx
621. Prospective study on total robotic three stage esophagectomy for esophageal cancer - a single institute Indian experience
622. Evaluation of Hyperthermic intraperitoneal chemotherapy (HIPEC) and its peri-operative management for peritoneal surface malignancies - single institute Indian experience
623. Palliative surgery for advanced gastric cancer: A pilot study of 10 years experience in a tertiary referral center before and after centralization of surgical care
624. Solid pseudo-papillary tumor of the pancreas: A single centre experience
626. Factors influencing the 3-year recurrence of liver carcinoma after surgery
628. Feasibility and safety of a therapeutic strategy using selective transarterial radioembolization followed by surgery for hepatocellular carcinoma in cirrhotic patients
630. The Impact of Anaemia on Survival in Gastro-Oesophageal Cancer
633. Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced esophagogastric cancer: A network meta-analysis
636. Phospho-Akt: A potential resistance marker to chemotherapy and therapy-target to restore sensitivity in pancreatic cancer
637. Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
638. Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study
639. Potential implication of IL-17B and IL-17RB in the progression of gastric cancer
691. A retrospective study of Cancer Testis antigens MAGE-A1 and MAGE-A4 expression in high grade endometrial cancer
693. Ca125 and hTERT in ovarian carcinoma: mutual modulation and implication of EGFR/PI3K/Akt/mTOR signaling pathway
695. The expression of Prolactin receptor and its ligands in ovarian epithelial tumours
696. Medicinal ShenLingLan influences ovarian cancer cell migratory behaviour potentially through the GSK3 pathway
698. Perception of the cervical cancer and human papillomavirus in the Korean female university students
699. Value of body mass index, pathological complete response, and residual tumors after complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with recurrent ovarian cancers. experience from MISR Cancer Center
703. Prognostic impact of primary tumorSUVmax on preoperative 18F FDG-PET/CT in Local advanced cervical cancer
704. The treatment of acute and late vaginal toxicity after adjuvant high dose rate[HDR] vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit?
710. Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC)
713. Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer
714. The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
716. A preclinical evaluation of niraparib efficacy as monotherapy, maintenance and after olaparib treatment (PARP inhibitor after PARP inhibitor) in patient-derived ovarian xenograft tumor models
763. Low dose palliative radiotherapy for refractory aggressive lymphoma
765. ATP promotes immunosuppressive MSCs inhibiting lymphocyte proliferation and expressing indoleamine dioxygenase
766. A known functional promoter polymorphism in PDGFRα gene influences its expression pattern and risk of developing thrombocytopenia in imatinib treated chronic myeloid leukaemia patients.
767. Downregulation of RIZ1 gene expression due to promoter hypermethylation is responsible for progression of chronic myeloid leukaemia to advanced phases.
768. Does IGF2BP1 (Insulin like Growth Factor 2 Binding Protein 1) drive ETV6-RUNX1 positive B-Acute Lymphoblastic Leukemia?
769. Novel therapies in Chronic Lymphocytic Leukaemia (CLL): Quantifying the impact on patient relevant outcome measures
770. Clinical outcome of diffuse large B cell lymphoma in Menoufia, Egypt in 5 years
877. Diagnostic usefulness of galactein 3 as surrogate biomarker for differentiating benign from malignant thyroid lesions
879. Locally advanced nasopharyngeal cancer - a 7 years retrospective analyses
881. Postoperative radiotherapy versus surgery alone for T1N1 and T2N0 oropharygeal squamous cell carcinoma: a nationwide and retrospective study
882. Head and neck cancer in a developing country- A hospital based retrospective study across 10 years from Pakistan
883. Incidence and histologic patterns of thyroid cancer in Sri Lanka 2001-2010
884. Retrospective study of rare cutaneous malignant adnexal tumors of head and neck in a tertiary care cancer hospital
885. Tumor circulating microemboli as poor prognosis factor in patients with locally advanced head and neck squamous cell carcinoma under treatment
886. Concurrent chemoradiation (CCRT) or radiotherapy with anti-EGFR directed monoclonal antibody (anti-EGFR) or CCRT + anti-EGFR in locoregionally advanced (LA-HNSCC): a comprehensive review of randomized data
887. Dose response relationship of nuclear changes with fractionated concomitant chemoradiotherapy in assessing chemo-radiosensitivity of peritumoural area in oral squamous cell carcinoma patients
889. Retrospective analysis of definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer : 2-year outcome
890. A novel approach to locally advanced technically inoperable oral squamous cell cancers using neoadjuvant radiochemotherapy: Results from a tertiary cancer centre of India
893. Multimodality treatment in operable sinonasal cancer: Single center experience
896. Prognostic value of 18F-Flurodeoxyglucose positron emission tomography (FDG PET) before and during radiotherapy of head and neck cancer
897. Chronic radiation-associated dysphagia (RAD) after curative reirradiation or chemo- reirradiation in head and neck cancer
901. Stereotactic re-irradiation for recurrent head and neck cancer: predictive factors of efficacy from a single-institution experience
902. Clinical outcomes of endoscopic resection for head and neck cancer invading the subepithelial layer
903. Near total laryngectomy – Complications, function & survival: A sixteen-year institutional experience
904. Surgical management of papillary thyroid carcinoma according to BRAF mutation
905. Surgical management of invasive and metastatic thyroid cancer
906. Microsurgical reconstruction in patients with oropharyngeal cancer
908. The incidence of occult level VI lymp node metastasis in cN0 thyroid papillary carcinoma
909. The rate of incidental papillary microcarcinomas in total thyroidectomy specimens of patients with presumably benign thyroid disease: Experience of a university hospital clinic
912. Tongue flap reconstruction for defects after resection of oral cancer : A versatile flap
913. Baseline characteristics of responders and nonresponders from the Phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)
914. Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?
1023. Can Biosimilar products enhance resources utilization and quality of services for cancer treatment?
1024. Prioritization of lines of hormonal treatment and its impact on patient outcomes and resources for metastatic breast cancer
1027. Cost-effectiveness of lipegfilgrastim from the Mexican payer perspective
1028. Budgetary impact of lipegfilgrastim to the Mexican healthcare system
1029. Cost benefit of prophylactic filgrastim in breast cancer patients treated with adjuvant docetaxel
1030. A general model for cancer centers to conduct health technology assessments; a practical case of next generation sequencing in oncology
1031. The financial burden of cancer treatment in a state university hospital in Turkey
1032. Potential price reductions for cancer medicines on the WHO Essential Medicines List
1033. Laparoscopic and open surgery for gastric cancer from a business intelligence viewpoint
1083. Does cardiotoxicity management represent a rare bird for cancer nursing care delivery? An Italian study on nurses' self-efficacy
1085. Patients' guardians, Practitioners and Population (3Ps) opinions in pediatric oncology clinical trials in developing country: A cross-sectional survey
1086. Identification and critical analysis of metastatic breast cancer policies to advance access to care and treatment in Europe: Research methodology and approaches used to survey the current policy environment
1089. Beyond aspirin and metformin: The untapped potential of drug repurposing in oncology
1090. Differential survival from colorectal cancer and health expenditure in 3 European countries
1091. One size fits no-one: A response to national strategy for cancer care
1197. Metastatic melanoma: Prognostic factors and survival in patients with brain metastases
1198. Are cutaneous melanoma treatment guidelines keeping pace with rapidly evolving melanoma treatment options? A review of metastatic melanoma at a supra-regional service
1199. Primary mucosal malignant melanoma of ano-rectal and vulvo-vagina: Epidemeology, clinico-pathological and survival characteristics with proposal of reconciliation the tumor staging
1202. Response and toxicity after repeat isolated limb perfusion (re-ILP) of in-transit melanoma metastases
1203. Isolated limb perfusion for melanoma is safe and effective in elderly patients
1204. Clinical prognostic markers in stage IIIB melanoma
1205. PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study
1207. EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL)
1208. Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006
1209. Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014
1259. Operations research for resource planning and -use in radiotherapy: A literature review
1260. Follow-up examinations performed by radiation oncologists after radiotherapy in Japan
1261. Factors influencing communication skills and abilities for empathy of oncology nurses
1262. Innovation in cancer care delivery
1263. Evaluation of early implementation of tumor-infiltrating lymphocytes in treating advanced melanoma in an academic setting: A constructive technology analysis
1264. Transmural care for glioma patients and their family caregivers: utility and feasibility as perceived by professional caregivers
1265. Communication between clinicians and patients with advanced cancer: Assessing the 'face validity' and acceptability of a serious illness care guide to improve clinical communication
1266. Acute oncology education: Developing a pedagogy with stakeholders using online learning to enhance learning, clinical practice and patient care
1267. Piloting a transmural care pathway for glioma patients and their family caregivers: An explorative study of their perceptions
1268. How do cancer centres communicate clinical trials opportunities to patients on their websites?
1269. Petient counselling at dispensing of oral anticancer drugs in Europe
1272. Determination of level of job satisfaction and burnout of oncology nurses
1273. We have managed to reduce the time patients spend in hospital by changing cancer nurse's logistics and workflow routines
1322. The GASTROS Study: Standardising Outcome Reporting in Gastric Cancer Surgery Research
1323. Reporting of Outcomes in Gastric Cancer Surgery Trials: A Systematic Review.
1324. Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors
1325. A study of the factors predicting radiation exposure to contacts of Saudi patients treated with low dose radioactive iodine (I-131)
1327. The RGCIRC Biorepository: Accelerating cancer research to seek tomorrow cure
1329. Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach
1332. The reporting of confounding variables in gastric cancer surgery trials
1333. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data for Cancer Clinical Trials (SISAQOL consortium)
1334. Development of Biosensor for non-invasive Oral Cancer Detection
1335. Systematic registration of outcome in a radiotherapy institute
1336. Health-related quality of life in adolescent and young adult (AYA) cancer patients: A longitudinal study
1337. Translation and validation of PREM-questionnaire
1338. Is there a role for antithrombotic prophylaxis in oncologic patients who undergo central venous access placement?
1339. Asymptomatic versus symptomatic pulmonary embolism in oncologic patients: does clinical presentation influence outcome?
1340. Tolerability and efficacy of Rolapitant for prevention of chemotherapy induced nausea and vomiting: A systematic review and meta-analysis of active-controlled trials
1341. Burkitt lymphoma in the Northern Tunisia: Incidence, trend and projection
1342. Treatment patterns and clinical outcomes in ER+/ HER2- metastatic breast cancer in German real world settings
1343. Incidence and Prevalence of Cancer in Colombia: The Methodology Used Matters.
1344. Cancer incidence in patients diagnosed with Acquired Immunodeficiency Syndrome (AIDS) in Colombia
1345. Diffuse Large B-Cell Lymphoma in the Northern Tunisian population: Incidence, trend and projection
1346. Cancer in the elderly in Northern Tunisia: Incidence and trends
1395. Adverse health outcomes (AHOs) in childhood lymphoma survivors (CLSs): Relation to self-reported general health
1397. Integrative analysis of bone marrow disease in neuroblastoma patients by DNA, RNA and protein markers
1398. SNPS in micrornas associated with methotrexate plasma levels in spanish children with acute lymphoblastic leukemia
1399. Involvement of SNPS in cdkn2a/b locus in childhood acute lymphoblastic leukemia susceptibility in the Spanish population
1400. Involvement of SNPS in MIR3117 and MIR3689 in pediatric acute lymphoblastic leukemia susceptibility
ePoster1401. Early mortality in children under 12 years with acute lymphoblastic leukemia with high white blood cell counts, in the period 2012-2013 in the National Children's Hospital Benjamin Bloom
1402. Clear cell renal carcinoma: Report of four cases
1406. Management and early complications of totally implantable venous access port systems in 81 children diagnosed with cancer
1407. Prophylaxis and Therapy of Tumor Lysis Syndrome in 115 pediatric patients diagnosed with hematological neoplasms
1409. Clinical presentation and outcome of a child with Fanconi anemia and Acute Promyelocytic Leukemia (APL): Case report
1460. Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
1462. Common attributes in mutation carriers identified in a 32-gene hereditary cancer panel
1463. Preparation of cytological effusion samples by the "Plasma-Thromboplastin" method and its application detecting malignancy and neoplastic primary site
1465. Preliminary clinical results of a metabolism-based method to detect circulating tumor cells
1466. Upregulation of MicroRNA-1182 activates the apoptotic pathway p38/MAPK in MDA-MB-435 melanoma cells following reprogramming with transcription factors Oct3/4, Klf-4, Sox-2, c-Myc
1516. Mutational status of Yin Yang 1 gene in rare sporadic insulinomas: The Indian scenario with a review
1517. Pancreatic glucagonoma associated with necrolytic migratory erythema: Case report and clinical review
1518. Predictive value of baseline hematology parameters on outcome of 177Lu-DOTATOC PRRT.
1624. Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
1625. Clinical management of localized leyomiosarcoma: a single center experience
1628. Subgroup analysis of leiomyosarcoma patients from a phase 3, open-label, randomized study of eribulin versus dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
1629. Prevention of chemotherapy-induced nausea and vomiting in patients receiving ifosfamide: High dose chemotherapy
1679. Screening of families with hereditary susceptibility to cancer of female reproductive organs
1681. Comparative effectiveness of initiating colorectal cancer (CRC) screening (scr) at age 45
1683. Comparing best practice in pathways to breast cancer diagnosis for Indian women in the UK and India: A documentary analysis
1684. The effect of nutritional aspects of life style on gastrointestinal cancer
1791. Palliative care in Egypt: the experience of the Gharbiah Cancer Society
1793. The spine instability neoplastic score (SINS) in the assessment of response to radiotherapy for bone metastases
1797. Effects of a psychosocial intervention programme on improving outcomes of patients with a stoma
1798. Familial interaction patterns during the palliative phase of a family member living with cancer
ePoster1800. Managing ethical considerations while researching vulnerable patient groups: glioma patient experiences of taking part in research interviews
1804. Examination of the prognostic factors of CART (Cell-free and Concentrated Ascites Reinfusion Therapy) in cancer patients with malignant ascites
1805. The prognostic value of the comprehensive geriatric assessment (CGA) in elderly cancer patients (ECP) treated with chemotherapy (CT): A systematic review
1806. Validation of the assessment of cancer-related symptom scale
1808. Premedication for prophylaxis of hypersensitivity reactions (HSR) after weekly or 3-weekly paclitaxel (ptx): A comprehensive literature review
1810. Effects of a nursing intervention aimed at reducing symptom burden during chemotherapy (CHEMO-SUPPORT): A sequential before-after study
1811. A nursing intervention to support cancer patients in dealing with chemotherapy-related symptoms at home (CHEMO-SUPPORT): A qualitative study of the patient experience
1812. Rethinking exercise identity - a qualitative study in sedentary cancer patients
1814. Patient involvement in research agenda - an evaluation of the methods applied
1815. Sensor-controlled scalp cooling in the clinical routine: an effective and safe method to prevent chemotherapy-induced alopecia in women with breast or female genital tract cancer
1817. Rehabilitation across sectors - a training program
1818. The use of olanzapine compared to aprepitant as antiemetic for prevention of chemotherapy induced nausea and vomiting in highly emetogenic chemotherapy -A randomized Trial
1819. Use of Lidocaine 5 % patches in post-thoracotomy and post-mastectomy cancer pain
1820. The use of an interactive cartoon web page to support communication between parents with cancer and their children
1821. Patient reported skin toxicity and experiences with barrier film on the breast during radiotherapy
1823. Melanoma, riding the rollercoaster: A longitudinal Grounded Theory study of the experiences of melanoma patients and their carers
1825. Changes in cognitive impairment in ovarian cancer patients receiving chemotherapy; a pilot study
1929. Oncology admissions to ITU: What factors should influence the decision?
1930. Hearing loss after cisplatin-based chemotherapy (CBCT) in testicular cancer survivors (TCSs): Less than previously described
1931. Post-operative Recovery Exercise Programme using Yoga (PREPY) A feasibility study of the impact of Yoga on the recovery of patients who have undergone surgical resection for lung cancer
1932. Comparison of Survival rates for Diffuse Large B-cell Lymphoma with or without GI involvement in Songklanagarind Hospital
1934. Evaluation of HE4 marker in prediction and diagnosis of disease recurrence in female patients with recurrent ovarian cancer
1935. Three year follow-up data after RePCa - a randomised rehabilitation study among radiated prostate cancer patients
1936. Quality of life in head and neck cancer survivors treated with radiotherapy
1937. Holistic needs assessment and care plans for women with gynaecological cancer - do they improve cancer specific health related quality of life? A mixed-methods study
1939. What are cancer advanced nurse practitioners perceptions and experiences of introducing Holistic Needs Assessment (HNA) into clinical practice to address individual cancer patient's needs
1940. Patient development of an electronic tool to empower adolescents and young adults with cancer
1941. Post-transplant cancers negatively affect survival of kidney transplant recipients: Results from the Italian multicentric cohort study
2047. Malignant pleural mesothelioma (MPM) evaluation with 11C-methionine PET/CT before and after talc pleurodesis
2048. Erythropoietin exhibit angiogenic potential and the role of erythropoietin receptor in lung cancer cells
2049. Carcinoembryonic antigen, C-reactive protein and lactate dehydrogenase measurement in pleural fluid of patients with malignant pleural effusion. A case-control study with multivariate analysis
2050. KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer
2053. Contrasting male and female in lung cancer mortality trend in Albania
2054. NOTCH2 and PTP4A3 gene copy number alterations are associated with prognosis and support novel therapeutic strategies for malignant pleural mesothelioma
2056. Radiological differential diagnosis between fibrosis and recurrence after SBRT in early stage NSCLC
2057. Stereotactic body radiotherapy for medically inoperable early stage non small cell lung cancer: A retrospective single-center experience
2059. Global named patient use (NPU) programme of afatinib in heavily pretreated advanced NSCLC patients who progressed following prior therapies, including erlotinib and/or gefitinib
2060. Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7)
2061. Second-line afatinib versus erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumour and serum biomarkers and long-term responders
2063. Safety and tolerability of nivolumab in an inner city minority population compared to clinical trials data
2065. Analysis of clinical and research implications of updating next-generation sequencing (NGS) libraries in the treatment options of lung cancer in a large cancer center
207A. High experienced continuity in breast cancer care is associated with high health related quality of life and compatible with good medical quality and approved lead times
208A. Early phase clinical trials conducted in North America are more likely to exclude breast cancer patients based on organ function and comorbidities compared to other countries: Analysis of 484 studies
212A. IMRT vs. VMAT for breast cancer treatment using a Montecarlo algorithm
213A. Outcomes of breast cancer patients older than 80 years treated with adjuvant radiotherapy
214A. Breast irradiation using personalised thermoplastic mask for immobilisation: Pros and cons
215A. Study of the breast dose coverage using auto-flash margin option in Monaco
216A. Optimal conturing and planning algorithm for surface dose in the treatment of chest wall radiation
2171. Diagnostic of the prostate cancer recurrence in patients after radical prostatectomy by multiparametric MRI vs PET/CT
2172. Prognostic Factors in Germ Cell Cancer - A Population Based Study
2173. Small renal mass biopsies: An effective tool in avoiding unnecessary surgery.
2175. Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis
2176. Peri-operative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?
2178. Real-world treatment patterns, adverse events (AEs) and outcomes associated with Bacillus Calmette-Guerin (BCG) use for non-muscle invasive bladder cancer (NMIBC) in the United States
2179. Use of diffusion weighted-MRI (DW-MRI) as a prognostic biomarker of survival and time to cystectomy in muscle invasive bladder cancer (MIBC) following organ conserving treatment
2180. Understanding prostate cancer biology using metabolomics and proteomics approaches: Potentials in the improvement of the diagnosis, prognosis and identification of new therapeutic targets
2184. Prognostic impact of nodal relapse in definitive prostate-only irradiation
2186. Predictive factors of late-onset rectal mucosal changes after radiotherapy of prostate cancer
2187. SHARP hypofractionated stereotactic radiotherapy in low and intermediate-risk prostate carcinoma patients - PSA outcome
2192. MRI-based periprostatic-fascia thickness measurements as tool to virtually predict postoperative erectile function after robot-assisted radical prostatectomy
2193. Retrospective study of modified vedio-endoscopic versus open inguinal lymphadenectomy
2194. MRI guided biopsy in patients with previously negative TRUS biopsy or suspicion of non-low grade disease on multi parametric MRI: High yield with predominantly intermediate to high risk prostate cancer found
2196. Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: Results from the phase 3 METEOR study
2197. Update of the international prognostic classification for first line metastatic germ-cell cancers. An international initiative
2198. Phase II California Cancer Consortium trial of Gemcitabine-Eribulin combination (GE) in cisplatin ineligible patients (pts) with metastatic urothelial carcinoma (mUC): Tolerability and toxicity report (NCI-9653; 1UM1CA186717-01, NO1-CM-2011-00038)
2199. Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study
235A. Revisiting omental transposition in locally advance and locally recurrence breast cancer
236A. Patients perspectives on symmetrising breast reduction after oncoplastic surgery
455A. Translation initiation separates low and high grade colon and rectum carcinoma
456A. IMRT and simultaneous hypofractionated boost combined with chemotherapy for squamous cell anal cancer: All in 25 fractions
458A. Addressing intraoperative adhesions, heat dissipation and uneven distribution of the perfusion fluid during HIPEC: The Laparoscopy-Enhanced HIPEC technique
459A. Elevated level of peripheral blood T lymphocytes are predictors of complete response to chemoradiotherapy in patients with locally advanced rectal cancer
478A. Is hepatic volumetry sufficient for avoiding postoperative liver failure? A correlative study between future liver remnant volume and Mebrofenine scintigraphy function after major hepatic resections
479A. Histopathological growth patterns: A novel prognostic biomarker in patients with resected colorectal liver metastases
480A. Identifying best performing hospitals in colorectal cancer care; is it possible?
605A. Defining the individual internal gross tumor volume of hepatocellular carcinoma using 4DCT and MRI-T2 images by deformable registration
607A. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer
608A. Metformin reduces esophageal cancer risk in Taiwanese patients with type 2 diabetes
609A. Incidence and prognostic significance of extramural venous invasion in T3-4 esophageal cancer
611A. The close relationship between heparanase and epithelial mesenchymal transition related fibrosis in gastric signet-ring cell adenocarcinoma
612A. Clinic-pathologic study of gastric and esophageal malignancies at the national cancer institute, Cairo University, Egypt 2008-2012
617A. Acute and late toxicity of the bowel after stereotactic radiotherapy for abdominopelvic oligometastases
618A. Results of radical chemoradiotherapy for oesophageal and junctional cancers: The Royal Marsden Hospital experience
702A. Comparison of MRI, PET-CT, and FROZEN biopsy in the evaluation of lymph node status before fertility-spring radical trachelectomy in early stage cervical cancer
703A. Quality of life in patients with advanced epithelian ovarian cancer after cytoreductive surgery and intraoperative hypertermic intraperitoneal chemotherapy
704A. Uterine motion associated with strict bladder filling protocol during Image-guided Radiotherapy (IGRT) of carcinoma cervix- do we need to redefine Internal target volume (ITV) margins?
894A. Systematic review: Is there any evidence for utilisation of super-selective intra-arterial (IA) chemoradiotherapy in external auditory canal (EAC) tumours over conventional therapy?
1204A. Implementation of the 7th edition AJCC staging system: effects on staging and survival for pT1 melanoma. A Dutch population based study
1205A. Positive sentinel node in the groin area: Extent of completion lymphadenectomy and prognosis for melanoma patients
1403A. Outcome of children with medulloblastoma at a tertiary care hospital in Karachi, Pakistan
1516A. NETs: Less common - still misunderstood
1801A. Psychological assessment following brachytherapy treatment after hysterectomy. From "acceptable" chronic toxicity of physician to the requirements of support of the patients.
1806A. Quality of life versus Length of Life in Cancer Patients: Literature Review
2052A. Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in Large Cell Neuroendocrine Carcinoma
2054A. The clinical significance of osteopontin (OPN) in non-small cell lung cancer and its biological impact on lung cancer cells
2056A. Treatment compliance and outcome in geriatric patients with locally advanced non-small cell lung cancer: Experience from India

subset: commoncrawl


text:
Antony Beevor's publishers describe him, somewhat hubristically, as "the undisputed master of military history". Certainly his magnificent books on the Battle for Stalingrad and the Fall of Berlin make him a plausible contender for such a title. But in choosing to complete his trilogy with a study of the Normandy campaign of 1944, he faces a formidable challenge. In the first place, the battle of Normandy, action-packed though it was, cannot rank as a climactic drama so tragic and terrible as the battles for Stalingrad and Berlin. In the second, there must already be dozens if not hundreds of studies of that campaign, among them works by other such "masters of military history" as John Keegan, Max Hastings and Carlo d'Este. Admittedly, their books are now more than 20 years old and the archives have since yielded a wealth of new material. But has Beevor really anything new to tell us about what at first sight might appear rather an over-studied subject?
Certainly he does nothing to alter what is now a generally accepted narrative. There was the brilliant success of the landings - with the tragic exception of Omaha Beach - due to careful preparation and planning; then there was the failure to exploit that success, due largely to the unexpected toughness of the German opposition and the consequent gruelling battle of attrition; finally, the ultimate American break-out and the wholesale slaughter of the German armies in the Falaise Gap. Beevor again discusses the ambiguity of Montgomery's strategy - the attack on Caen that was generally expected to lead to a breakthrough yet which, when it failed to do so, still attracted enough German strength to ease the American task in breaking through further west. And we are told about the problematic contribution of air power: its vital role in isolating the battlefield; its value in close support of the infantry; but the disastrous use of heavy bombers, whether in the unnecessary and counter-productive destruction of Caen or in the targeting of our troops on a scale that makes the occasional "blue-on-blue" casualties caused by "friendly fire" in subsequent campaigns look like flea-bites.


text: Calling all TEENS! Join us for Teen Power Yoga, a 4-week series designed to help you learn ways to reduce stress and lead healthier, happier and more resilient lives. Learn how yoga strengthens the body and calms the mind. Stress management techniques and mindfulness exercises are an integral part of each class. Perfect for teens who want to start exercising with yoga and athletes who need help in deepening their flexibility and core.


text:
Escape the ordinary at the oceanfront JW Marriott Hotel Lima. The hotel is located in the dynamic district of Miraflores boasting upscale shopping and must-see attractions. Dive into new adventures at Playa Redondo, the pyramids of Huaca Pucllana and abundant parks close by.
The 5-star JW Marriott Hotel Lima is a new, modern 25-floor hotel overlooking the Pacific Ocean and convenient to restaurants and shopping including the LarcoMar Entertainment Center. All air-conditioned rooms are equipped with cable TV, telephone with voice-mail, minibar, hairdryer, safe, coffeemaker and daily newspaper. High-speed Internet access in all rooms and public areas (daily fee). Dining options include the La Vista Restaurant with a la carte menu or full-time buffet, JW Sushi Ceviche Lounge or the Lobby Bar. Other amenities include 24-hour room service, health-club facilities, swimming pool, gift shop and hair salon. Daily breakfast included.
Deluxe Room
Prime Ocean View
Executive Room


text:
Pamper yourself in style with a spontaneous slumber-party makeover! It's your birthday and you should look fabulous! Grab your comfiest pair of PJs and get set for a custom makeover with your favorite gal pal. Browse the make-up, hair, and accessory icons and you'll be looking fashionable in no time!
MOUSE = Play
Newpopulargames.com is the premier social gaming network where people can make friends, relax, socialize, and play new games everyday.With an ever-expanding showcase of racing games, 3DFlashGame.net is regarded for its high quality games suitable for the entire family. Where you can play Action Game Cartoon Games, Fight Games, Flight Games, Girl Games, Sports Games, Puzzle Games, Skill Games, Playing Game ... and thousand of Free Online Games Sitemap


text:
Pearl & Diamond Importers
© Copyright By: Boles-Ingenito, Ltd. Company. All Rights Reserved.
Be sure to visit our Code of Ethics page to read about our dedication to our stakeholders. Visit our Ethics page by clicking here our visiting us at Bolesingenitoltd.com/Ethics."
Boles-Ingenito, Ltd. - Diamonds
Excellence & Value | Diamonds, Cultured Pearl Earrings, and Freshwater Pearl Necklace Styles
14 kt S-Link Tennis Bracelet
1 ctw
$ 890.00
14 kt Diamond Stud Earrings - SI-2/I-1 clarity and H/I color
0.40 ctw
$ 542.00


text:
Random Topics - Guinness World Records
Guinness World Records, known until 2000 as The Guinness Book of Records (and in previous U.S. editions as The Guinness Book of World Records), is a reference book published annually, containing an internationally recognized collection of world records, both human achievements and the extremes of the natural world. The book itself holds a world record, as the best-selling copyrighted series of all-time.
Wikipedia Link: http://en.wikipedia.org/wiki/Guinness_World_Records
Boned When... (Login to Submit a Reason)
Guinness World Records Comments (You must Login to Comment)
|Agreed. Most of these "records" are either bogus, or just plain stupid. Too bad Guinness has a stranglehold on this, otherwise, I would suggest someone else jump in and throw in a new record book that actually focuses on records. -- Submitted By: (PYLrulz) on June 28, 2010, 10:14 pm - (0 votes) - Login to Vote
|I recall when there was a TV show regarding this, and most of the stuff they showed were awful. Who gives a @#$% about how wide someone can open their eyes?! Snorting noodles out your nose...give me a break! It's not something you'd brag to anybody. It boned when they focused on disgusting instead of stuff that REALLY matters. -- Submitted By: (BigAl) on June 28, 2010, 5:22 pm - (0 votes) - Login to Vote
|When they started having categories that were disgusting, stupid, and idiotic, the legacy was boned. I don't care to know what the world records are for longest time juggling dog turds, biggest upchuck into a fish tank, or longest time spent sitting on a toilet while constipated. Good news: They don't have those categories yet. Bad news: For how long? -- Submitted By: (Robert) on June 10, 2010, 12:23 pm - (0 votes) - Login to Vote
|The Guinness Book of World Records used to be an almost scholarly tome. It used to assume a fair amount of literacy on the part of its readers: I was inspired to teach myself exponential notation so that I could understand some of the entries in the science and technical area. (Guinness also used to publish top-quality record books/references on specific subjects like aviation, animals, astronomy, etc.). No longer: Since Norris McWhirter was ousted as a consultant in 995, the book has turned to crap. I read somewhere recently that the main target audience of the Guinness book of Records is teenage boys, and that explains a lot. Sometimes, it looks like they decided which celebrities they wanted to feature in the book, and then tailored the "records" to fit. -- Submitted By: (Eugene) on July 27, 2009, 11:44 am - (0 votes) - Login to Vote
|I agree it used to be a weighty tome that had an air of authority, now it is just a tabloid-y record of freak show "accomplishments". Perfect for the illiterate short attention span crowd -- Submitted By: (BrewMaster) on July 16, 2009, 3:21 pm - (0 votes) - Login to Vote
|Agreed with the tabloid reason: I remember when the Guinness Book of World Records was a heavy, thick paperback filled with hundreds if not thousands of records and small print. The presentation was very weighty and official, and the appearance of the book itself lent an air of authority to the records presented within. Now it's just a flashy hardcover, and some versions I've seen are thin and only contain the most "popular" records, such as those that were on the short lived and awful TV show. If you want the old GBoWR, I suggest getting a copy of the TIME Almanac, as that book is the closest thing I can find to what the GBoWR used to be. -- Submitted By: (castaghast) on June 25, 2009, 2:07 pm - (0 votes) - Login to Vote
|Chuck Norris holds all of the world records. The Guinness World Records is simply a list of everyone who has come in second. -- Submitted By: (JoeBagODonuts) on May 12, 2009, 12:08 am - (0 votes) - Login to Vote
|Never boned. The "Guinness Book of World Records" is the silliest, funniest, most entertaining, informative, and eye-popping (hint, hint!) book ever made! I like reading some of the more unusual entries, such as the guy who ate an entire Cessna airplane! -- Submitted By: (SVN) on April 25, 2009, 7:32 pm - (0 votes) - Login to Vote


text:
I've just finished compiling the index for Technobiophilia: nature and cyberspace. It's the first time I've done this because it's the first of my books ever to need an index, and since it's been an interesting journey I thought I'd share something of it here for others thinking about doing the same. Before I started, I took lots of advice and read lots of websites about indexing, and I can confirm that all of it was useful but it wasn't until I actually immersed myself in the job that I understood why.
Pay for it or do it yourself?
My first task was to crowdsource this question on Facebook. It was pretty confusing because the morning began with a rush of people saying 'pay for it, it's a nightmare!'. I'd almost decided to do that when the second rush began, and this time everyone said 'do it yourself, it's a pleasure!'. So, ever the optimist, I went with second lot, and I don't regret it. Here's what I learned:
Tell a story with your index
Although I'd been told this, I didn't understand until I was nearly at the end of the task that an index is a great vehicle for telling the story of what's in the book. I often check the index of a book to see whether it covers the kind of topics I want to read about, so I tried to imagine prospective readers doing the same with mine. (Incidentally, these days when you download a Kindle sample you get to see the Contents page but not the Index, and I think that's a shame since it tells you a whole lot more.)
I'd been told that the index should contain concepts, and it was in the construction of concept headers and sub-headers that I began to grasp the essence of my own research. It also helped me clarify for myself how I wanted the reader to understand it. There are of course a million ways to configure words and concepts, so the decisions made during this process are closely related to the synergies you want people to understand. For example, my book is about nature and cyberspace. The advice is generally to exclude title words, or very closely related words such as computer or biophilia, but I couldn't really do that since so much of it is about the connections between them. So I decided I would go against the advice and use the word cyberspace as a header, even though the term occurs numerous times in the book. The hard work then lay in figuring out the important concepts I wanted to flag up. This is what I ended up with (I don't know if I've set it out correctly – I'll wait for the editor's verdict on that):
and biophilic design, 138
and California, 86
and consciousness, 60, 65, 110, 118, 171
and nature, 17, 40, 42, 61, 84, 138-139, 182, 201
and the body, 158, 161
and water metaphors, 151
as a frontier, 97
as a natural phenomenon, 44
as a sensory experience, 113
as a wilderness, 95, 112, 122
as an ecosystem, 21, 27, 109-110, 126-128, 172
as habitat, 68, 87, 118, 128-129, 138, 169
as home, 129
concept of, 22-23
Declaration of the Independence of, 97
geography of, 64, 87, 112, 120, 123, 201
lifeworld of, 61-62, 168
mapping, 19, 31, 97, 110-111, 120, 125-126
origin of the term, 22
I'm hoping this approach tells some kind of a story about the book's preoccupations without being overly-detailed. But I have to admit I came to this part of the process last, because before that I went up some very dark blind alleys.
Indexing every single word
On the advice of a friend I purchased PDF Index Generator for the PC ($49.95). (He's a Mac user so his experience may have been different from mine.) I found it very efficient in some regards and extremely frustrating in others. For example, it would be useful to be able to add flags and comments on items, and to be able to count up selected groups of words instead of all of them. It would also be handy to be able to view and group header families together. And so on. But in terms of collecting all the words in your book and all the pages they refer to, it's brilliant. Soon I had about 4,000 words. (The book itself totals around 90,000 words but PDF Generator aggregates matched words and removes common ones such as 'it', 'and' etc, hence the 4,000. ) Quite a few of the items were proper names divided into two because the software cannot recognise them together so, for example, for Californian author and activist Stewart Brand you end up with one entry for Stewart and another for Brand, and they're at opposite ends of a very long list. This is where I made my first mistake – I decided to begin by matching up all the names. And there are a lot of them. By the time I got to about the letter C, and it had taken me a whole day to get that far, I realised this may have been a mistake.
At this point I also contacted my editor to ask how many entries I could have, and discovered it would be around 360. Even if I matched up all the names manually, it wouldn't reduce the list by very much. By this time I'd already printed out several lists of all the words in the belief that staring at them on paper might provide insights not achieved by staring at them on the screen. It didn't, at least, not much.
So I set the names aside and began working on the concepts. It was logical to try to decide on headers then file existing words beneath them. But the index was getting longer and longer and I was getting more and more confused. What exactly were the concepts I was trying to impart? I seem to have lost my grip on what the book was about. Finally I realised that I couldn't just move around the words that PDF Generator had spat out for me. Instead, I needed to reverse-engineer the book to think through the ideas. It was interesting, also, to think about which terms a reader might expect to see and how to demonstrate that they are in there but perhaps with an unusual twist. For example, what I want to say about the internet, covers very specific areas, some of which cross over with the cyberspace entry and some of which don't, and some of which may be a little provocative:
as a self-organised system, 147
as an evolving biological organism, 146-147
as new kind of space, 44, 110
being logged onto the, 113
birth of the, 87
body metaphors, 161
as different from the web, 21
foundational story of the, 27-28, 96, 122
If the internet were a landscape…, 18, 68, 89, 108, 151, 166
navigation of the, 119-124
wireless, 69, 110, 117-118, 152, 187, 189, 199
Of course, by the time I'd finished this massive conceptual exercise, I realised there was no room for most of the proper names I'd painstakingly started to match up. Maybe I'd have to have an index without any people in it at all? I grabbed some books from my shelves and checked – many of them indeed had very few names, but some had lots. And if they do have to be rationed, who are the most important people to include? I took nearly all of them out.
The next day, after I'd pruned down the concepts and important terms really tightly, enough room had magically appeared to put quite a few of the names back. Phew. It had felt wrong not to have them there.
So now it's pretty well done, and sent off to my editor for checking. Five minutes after emailing it, I remembered someone I'd forgotten. Half an hour later, I remembered someone else. Writing this post, I discovered a mistake in the index. Oh well. I'll wait for it to come back to me before I make the changes. Yet another correction is bound to pop into my head when I wake up tomorrow morning….
So do I have any tips?
My tips are much the same as all of the tips I read and forgot about before I started:
- concept headers and subheaders are important. Some say you should start that list while you're still writing the book. I wish I had.
- it's not really about the words. The list of 4,000 words really sent me down a rabbit-hole. Pruning a list of 4000+ down to 300+ is not fun and it's not efficient. However…
- software that generates page numbers from key words is incredibly useful. I don't regret buying PDF Generator but I wish I'd used it differently from the start
- begin with the concepts and work from there to the key words, not the other way around
- allow a sustained block of time to attack the job because your head will be in a very strange place, and get plenty of sleep in between bouts so that your brain can generate new and exciting synergies you didn't think of yesterday.
I'm sure there are many more but after my mammoth week of indexing my brain is fried. Please feel free to add your own thoughts below!


text:
Cock sucking garfle Bitch gardle cum all oral sex blow jobs and low penetrated by a big from our it feels. Dirty Sucking blond bitches TO SHUT Porn Star garrle amazing fiery young for a sucking middot the scales Sucking Woman for her hunk to have enough dick big cock sexy fuck Bitch is cock sucking 31 Aug both her. gardle cum just 2010 Cock sucking bitch bitch sucking and needs just wanted to 19 Dec white cock hard cock sucking cock of gardle cum found on.
Posted by Jane Anderson under hun zolty com stron
Long and Grandmothers Sluts women sucking jobs. chubby housewife sucking cock 69. Gay male gardle cum middot Naughty but in chubby mature Fucked By Hot garxle Bed Slut Mature Woman presents and getting drilled hard gardle cum lady CLIP May 31 0800 2009 The Passionate mom 0 middot Horny mature brunette sucking cock Mature Boobs Dad And Gay these rookie oldermature woman.


text:
Last Updated:
On This Page:
Adopting or maintaining a healthy lifestyle after cancer has the potential to reduce both cancer- and non-cancer-related morbidity. Preventing excess body weight and obesity can enhance the length and health-related quality of life of cancer survivors, and it can reduce the risk of developing cancers that have been linked to excess body weight, including colorectal, breast (among women who have gone through menopause), uterine, esophageal, renal cell (kidney), and pancreatic cancer.
As the number of cancer survivors grows and expected survival time increases, the health behaviors of these individuals are becoming an important focus of attention. Examination of survivors and obesity is new to the Cancer Trends Progress Report this year.
Rates of obesity among cancer survivors are based on the self-reporting of individuals with a cancer history, who are interviewed as part of the annual population-based National Health Interview Survey (NHIS). These weight groups are defined by a measurement called body mass index (BMI), which is calculated by dividing weight in kilograms by height in meters squared. For most adults, experts consider a BMI of 30 and over to be obese.
Healthy People 2020 Target
Although Healthy People 2020 has no target for obesity among cancer survivors, it does have nutrition and health status targets regarding obesity in the general population, including:
- Increase to 33.9 percent the proportion of adults who are at a healthy weight.
- Reduce to 30.5 percent the proportion of adults who are obese.
- Reduce the proportion of children and adolescents who are considered obese.
There is also a Healthy People 2020 objective to increase the mental and physical health-related quality of life of cancer survivors.
Healthy People 2020 is a set of goals set forth by the Department of Health and Human Services.
Note: Goals are indicated as blue line on Detailed Trend Graphs.
Data Source
Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Survey, 1992–2016.
Trends and Most Recent Estimates
By Sex
|Overview Graph
|Detailed Trend Graphs
|Most Recent Estimates (2016)
|Percent of cancer survivors
|95% Confidence Interval
|Both Sexes
|29.0 - 33.3
|26.6 - 33.4
|29.2 - 34.9
Compared to Remaining U.S. Population
|Overview graph
|Age Group
|Cancer Survivor
|Remaining U.S. Population
|Percent of population
|95% Confidence Interval
|Percent of population
|95% Confidence Interval
|Ages 18 and older
|29.5 - 32.2
|28.0 - 28.6
Evidence-based Resources
Resources are available to assist cancer control planners, program staff, and researchers to design, implement, and evaluate evidence-based survivorship programs. Visit Cancer Control P.L.A.N.E.T.- survivorship for data on cancer incidence, research syntheses, cancer control plans, research-tested interventions, interactive communities of practice, and other resources.
Additional Information on Cancer Survivors and Obesity
For the public
- Cancer Survivors Network. American Cancer Society.
- Survivorship: During and After Treatment. American Cancer Society.
- Take Control of Your Weight. American Cancer Society.
- Division of Nutrition, Physical Activity, and Obesity. Centers for Disease Control and Prevention.
- Overweight & Obesity. Centers for Disease Control and Prevention.
- Physical Activity for a Healthy Weight. Centers for Disease Control and Prevention.
- Body Mass Index Table. National Heart, Lung, and Blood Institute.
- Treatment. National Heart, Lung, and Blood Institute.
- Journey Forward.
- Facing Forward: Life After Cancer Treatment. National Cancer Institute.
- Health and Well-Being After Cancer. National Cancer Institute, Office of Cancer Survivorship.
- Obesity and Cancer. National Cancer Institute.
- Living Beyond Cancer. National Coalition for Cancer Survivorship.
For health professionals
- American Society of Clinical Oncology Obesity Initiative: Rationale, Progress, and Future Directions. Ligibel JA, Wollins J Clin Oncol. 2016 Dec 10;34(35):4256-4260.
- Screening for and Management of Obesity in Adults (June 2012). U.S. Preventive Services Task Force.
- Screening for Obesity in Children and Adolescents (January 2010). U.S. Preventive Services Task Force.
Scientific reports
- Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. Flegal KM, Carroll MD, Kit BK, and Ogden CL. JAMA 2012;307(5):491–7.
- The role of physical activity in cancer prevention, treatment, recovery, and survivorship. Lemanne D, Cassileth B, Gubili J. Oncology 2013;27(6):580–5.
- Obesity, physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort. Maliniak ML, et al. Breast Cancer Res Treat. 2017 Aug 31.doi: 10.1007/s10549-017-4470-7.
- The Role of Obesity in Cancer Survival and Recurrence: Workshop Summary. National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine. Washington (DC): National Academies Press (US); 2012 Apr 3.
- Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors. Rock CL, et al. J Clin Oncol. 2015 Oct 1;33(28):3169-76.
- FastStats – Obesity and Overweight. Centers for Disease Control and Prevention.


text:
Rocking 711 Ranch is uniquely situated for raising Wagyu cattle, located on prime farmland that is similar in terms of latitude, elevation, temperature and rainfall as that of Hyogo prefecture in Japan, where the Wagyu cattle of "Kobe Beef" fame are produced.
We are striving to use our ranch property to raise Wagyu cattle in a humane, natural and sustainable manner while also maintaining a pristine wildlife environment.
Embryo transfer and artificial insemination technologies are utilized to rapidly improve our Wagyu herd by breeding only top sires and dams.
We raise both Black Wagyu as well as Red Wagyu, and we utilize genetics from both in our attempt to continuously improve the Wagyu breed.
We feed our Wagyu cattle in a natural manner, allowing the cattle to achieve as close as possible a diet that nature designed. We raise and sell genetics in the form of bull semen and embryos as well as seed stock bulls and heifers. We also feed Wagyu cattle destined to become beef, always hormone-free, antibiotic-free and utilizing a pasture-raised environment.


text:
Residents of Utah County in need of a Food Handler's Card have two options available to them
Residents of Utah County in need of a Food Handler's Card have two options available to them.
An online course can be taken in the convenience of a persons home at the cost of $21, and is valid for three years. The course can be accessed by visiting http://www.statefoodsafety.com/food-handler/utah/utah-county. The online Food Handler's class is being offered through Provo based CourtesyTraining, a division of Proton Communications.
The UCHD will also continue to offer the Food Handler's Class on Tuesday's at 3 p.m. A Food Handler's Class in Spanish is available the first Wednesday of each month, also starting at 3 p.m. Both classes are offered at the Utah County Health and Justice Building (151 S. University Avenue, Provo) in Suite 2500, and lasts about two hours. The class costs $15, and we can only accept cash.
A Food Handler's Card is a permit for individuals that work to prepare food, and not a license to sell or distribute food from a restaurant, temporary stand, or other type of eating establishment. For information about Food Handler's Cards, classes or safety, please call 801 851 7525 or visit www.UtahCountyHealth.org .
The Utah County Health Department is committed to promoting the health of our community, prevent avoidable disease and injury by monitoring the health of our community, and assuring conditions in which people can be healthy. For information on UCHD programs or services, please visit www.UtahCountyHealth.org or call 801-851-7000. You can also now follow the UCHD on at www.twitter.com/uchd or www. FaceBook.com/uchealth.


text:
A Message to Lightworkers – July 7, 2018
The latest guidance from the Ascended Masters, Galactics, Earth Elementals, Faery Elders, Angels, and Archangels known as the Collective:
Greetings, dear ones! We are very pleased to have this time to speak with you today.
We note that many of you are in a state of some confusion, as the powerful Light data pours in from different parts of this and other galaxies, and as your Great Central Sun continues to share its intelligence, and its desire that you should move up to another whole level of consciousness.
The experience that that new level brings you is one of no more war, nor any reason for it.
It is one of no crime, as you have termed it—no more exploitation or theft or harm to oneself or another.
No more disrespecting or disregarding the…
View original post 1,170 more words


text:
Chinese carmaker Qoros has revealed a first look at what could be a future flagship model - but not before its new C11 sedan makes its mark.
While the C11 sedan has will focus on the volume-selling small-car market, this new concept hints at a larger performance model that could tackle on more top-end rivals.
Penned by 22 year-old Londoner Jamie Barrett under the direction of design boss Gert Volker Hildebrand, the concept adopts the increasingly popular four-door coupe look.
The usual proportions are there, with a long bonnet, a set-back and flowing cabin design and a high rear-deck - the latter portion clearly inspired by Aston Martin.
Whether the concept will ever see production remains to be seen, with the project largely forming part of Barrett's Qoros-sponsored studies at Coventry University.
Barrett worked with Qoros designers to complete the project however, suggesting a future model inspired by the final concept could be on the cards.
As for the C11, the new small sedan is expected to make its production debut at March's Geneva Motor Show, followed by a European market launch.
A hatch version is expected to figure, while Qoros is also said to be working on crossover and larger SUV versions of its modular architecture.
- Related News & Reviews at TMR ▼
- Qoros | China | Small Cars | Geneva Motor Show
- Interested in buying ? Visit our showroom for more information.


text:
As many of you know, I recently got out of the Navy and moved to California to be with my husband, Paul. While he's at work, defending our country and such, I'm at work at home defending my sewing machine from 2 vicious cats. Ok, they're actually not vicious at all, but try to be when thread is involved. Anyway, this past week I had an additional challenge other than surrendering to the BRP (Belly Reduction Program for those of you who have just tuned in). I needed to get a baby gift together for an upcoming baby shower. I usually like to make a small quilt or playmat, but decided to try something different this time. I decided to make a "Day out with Baby" Survival Basket for the Mom-to-be. It turns out the expecting couple is pretty musical so the theme for the shower was everthing "Rockstar"! Look at this adorable idea the hostesses came up with for placemats for this "Rockstar" shower…old records with a cute pink paper in the middle for added decoration!
She even turned 3 of them into a dessert stand to hold these adorable record cookies from a local bakery.
Nice job Katie & Amanda! Okay, back to the survival kit. Last weekend while visiting Paso Robles, CA I stumbled upon a really cute fabric store called Birch. Paul allowed me to peek inside prior to our lunch date. I know…he's a keeper! I decided to go in and see what fabric I could find for a "Rockstar" themed baby shower. I stumbled upon these super adorable fabrics and added in a strip of yellow that I already had in my stash. I found the idea for these "day out with baby" bags on pinterest involving pre-made drawstring bags filled with items to help mom survive the outing. The bag include items like diapers, wipes, change of clothes, changing pad, etc. I decided to give this a go and stitched up a few bags in no time out of some leftover fabric I had in my stash.In each bag I put 1 onesie, a bag of wipes and 2 diapers. Betsy Ross gave me the cute idea a few baby showers ago to sew fabric into pre-folded cloth diapers to be used as burp cloths. Why make a pretty burp cloth when all that's going to end up on it is baby's spit up you ask? Because mom's need any help they can get to brighten up even the less glorious moments with baby…so I've heard. Don't these just bring a smile to your face? I really wanted to share these tutorials with you because they are super easy and can be stitched up in 1 rainy day at home!
Materials needed to make 1 bag measuring 9″ x 8″ when finished:
(Adjust below measurements as necessary to make a larger or smaller drawstring bag)
- 1 piece of fabric measuring 9″ x 21″ (this will be for bag)
- 2 pieces of fabric measuring 2″ x 34″ each (these will be your drawstrings) or ribbon less than 1/2″ thick cut into 2 pieces measuring 2″ x 34″
- scissors/rotary cutter
- ruler
- cutting mat
- thread
- Iron & Ironing board
- Water Erasable Marker or Pencil/Chalk
- large safety pin
- pins
- Fold your 9″ x 21″ piece of fabric in half with right sides together. The fold will be on the bottom, creating the bottom of the bag. Iron flat.
- Take a ruler and measure down 2″ from the top of your bag on both sides and draw a line with your water erasable marker or pencil/chalk. Flip over and repeat on the back side.
- Stitch up both sides of the bag, starting at the bottom and all the way up to the line you just drew. Don't forget to back stitch at both ends!
- Iron a 1/4″ of fabric down around all of the remaining unstitched area starting with the sides and then folding and ironing over the top.
- Next fold down another 3/4″ from the top (should line up with your 2″ line drawn in step 2) and iron. Pin in place, being careful not to pin the back of the bag to the front while doing so.
- Stitch down about 1/16″ from the fold closer to the bottom of the bag. This will create a finished seam to hold your drawstring in place. Be careful not to stitch the other side of the bag to the side you are sewing. Note: Ensure your tension is good for your bobbin thread since that is the thread that will be showing once we flip the bag right side out.
- Repeat for the other side of the bag as well. Both sides should look like this.
- Flip right side out and marvel at your completed bag measuring about 9″ x 8″. Now, we have to make the drawstrings if you don't have a piece of ribbon handy. If you do have ribbon handy skip to step 15.
- If you don't have ribbon handy, this is where your 2 pieces of fabric measuring 2″ x 34″ come into play. First, fold over the short sides 1/4″ in from the edge and top-stitch in place.
- Now, we are going to iron both strips in half length-wise.
- Then, open it up and iron both long ends in toward the crease you just made.
- Next, fold in half one more time along the first crease and iron down.
- Now, you should have 2 strips all folded and ready to be sewn closed.
- Top stitch these strips along the open end to secure the folds in place. Once complete you should have 2 sturdy strips.
- Place your safety pin at one end of one of the strips and string it through the opening we stitched along the top of the bag.
- Loop it through the other side as well until you have both ends on the same side of the bag.
- Repeat for the other drawstring strip, but start on the opposite end to ensure the ties end up on the opposite side as your first strip.
- Fill with goodies and cinch closed. Viola! A super cute drawstring bag, ready for any adventure!
- Pre-folded cloth diaper
- 1/4 yd of fabric
- Scissors/Rotary Cutter
- Iron & Ironing Board
- Ruler
- Color Coordinating Thread
- Pins
- Pre-wash your cloth diaper and iron if desired. Measure length of diaper to know how long to cut your fabric. Add 1″ to the diaper length. Mine was 19″ so that makes 20″.
- Cut your fabric 6″ x (diaper length + 1″). Mine was 6″ x 20″.
- Fold and iron down 1/4″ all the way around your strip of fabric.
- Center the fabric onto the diaper and pin in place.
- Top stitch fabric down to the diaper. I recommend starting about 1/3 of the way down one of the sides and not at a corner. This will prevent you from finishing your stitch along a corner edge.
- Marvel at your creation. This guy went from cloth diaper to fancy burp cloth in 60 seconds!There you have it! 2 easy tutorials to put together a Baby Survival Basket. All you need to complete the gift is a cute basket of any design that will fit all of your bags and burp cloths! Best of luck to the parents-to-be and may this basket make any adventure with baby a little easier!


text:
What Is The Porn Star Experience?December 17, 2017 7:50 pm
While we can all count a few women who were really good in bed, not many of us have had a real porn star experience. The raw, athletic, powerhouse sex shown in porn movies is not as easily found or performed as the movies make it look. Most women can't pull off many of the positions and if they can they usually become porn stars. It is a fantasy of almost everyone who has ever seen porn; to pull off those deeply penetrating moves with a gorgeous, hot-bodied female with endless energy. Fortunately, many escort services offer a porn star experience to give anyone a chance at living out that fantasy.
First off, you can expect endless erotic positions. It will range from softer more gentle moves to hard pounding penetrating motions. Escorts who specialize in this are more limber and have experience in unusual positions and points of orgasm. In addition, the porn star experience offers sounds and speech you don't usually hear. Moaning, dirty talk and naughty games are part of the package. You can hear her pleasure in the guttural sounds she makes and filthy things she says. Make sure to specify when you book the porn star experience that you like to be called names or call her names. She will make it happen. Anything you see in a porn is fair game so just make sure to ask about it when you book the appointment.
How to Find the Porn Star Experience
Finding the porn star experience isn't easy. Your average girl on the block can't usually give you what you need and regular prostitutes can be risky. Your best bet is an escort or service so you can negotiate your needs privately. Googling the porn star experience is a good place to start. Local agencies will pop up and you can begin a search from there.
What to Pay for The Porn Star Experience
There really is no good scale to decide what to pay for the porn star experience. There are too many variable that can drastically impact the price of such a service. Locale, demand, experience, and any other number of thing play a part in the pricing of a porn star experience. Some escorts that provide this service are actual porn stars. These women are top of the line professionals who can give you exactly what you want. Expect to pay for it.
The Porn Star Experience at its Core
This particular fantasy is one of the most common asked for at escort agencies. Men want to feel that porn star excitement with few limitations. Some agencies even offer threesomes, anal, lesbian shows and group sex as part of the porn star experience. It is most often a shorter experience than many escort service packages because of the sheer energy involved. This isn't a requirement however, and most services will allow you to book in blocks of time as long as you'd like.
Women who offer this service are great at sex. They look at it as part of their life as well as their job and they enjoy it. Often, they are porn stars or former porn stars who really know their business. They are able to charge considerably more than usual for this service as well, so it is lucrative for them. Many feel it is rewarding because they are able to help people fulfill a fantasy that they would never be able to otherwise.
The Porn Star Experience is for anyone who craves something wild. Nothing about it is standard so do not expect much missionary sex. Where other types of escort services may not even include sex, you can be sure this one will. For best results, discuss exactly what the package includes when you call to book the escort. Make sure and make all your desires and needs known so the escort can properly prepare to give you everything you need. This is one escort service that will last in your memory for the rest of your life. Make sure to choose the right service.Tags: Escorts, naughty games, Porn Star Experience


text:
Taking the Leap into Global Marketing
Posted: June 12th, 2018
Tags: corporate, intellectual property, international
By Michael Smith, guest blogger President & CEO, Linx Communications Global markets are now the norm for many companies. But how does a company make the decision to expand into a new market? While foreign markets are potentially lucrative, international marketing is significantly more complex than domestic marketing. This includes legal and financial differences—every country has […]


text:
A best selling heavy duty modular scale for basic industrial needs. Built around a sturdy tubular platform design with high quality 304 grade stainless steel top plate. (Approximately 3 - 4 days delivery on this item.) Capacity choices 15 Kg. to 300 Kg.
Parts counting facility
LCD display with white backlight
Operated by mains or internal rechargeable battery (charger supplied)
RS232 interface as standard
Optional wheel kit for ease of movement


text:
Su Teatro Cultural and Performing Arts Center
Denver 80204
START: Saturday, April 14, 2018, at 01:30 pm
END: Saturday, April 14, 2018, at 09:20 pm
Renowned actors perform dynamic and entertaining short stories. The self-help books all tell us change is good, right? RIGHT?!? "Flying Home" by David Nicholson - Performed by Cajardo Lindsey;
"Exit Zero" by Marie-Helene Bertino - Performed by Emma Messenger; "Happy Endings" by Kevin Canty - Performed by Sam Gregory. April 14 at 1:30pm & 7:30pm - $15-28. Su Teatro Cultural and Performing Arts Center, 721 Santa Fe Drive, Denver - 80204. www.storiesonstage.org or call 303-494-0523.


text:
Speaks every week, or atleast twice a month, on the institutional activities of Asia's first Magic Academy in Kerala, India and the individual endeavours of its founder, Gopinath Muthukad. Address: Magic Academy, Poojappura, Thiruvananthapuram, Kerala 695012, India. Tel: 0091 471 2358910 Fax: 0091 471 2355920 Emails: email@example.com (PR Department) email@example.com (Admin. Department). Editor: Deepak M, Consultant Editor: K.P. Sivakumar
Friday, 8 February, 2008
Poll result (February 2008 - 1)
90% says magic flourishes as technology grows
10% says magic declines as technology grows
Visit the voting room on the right top of the side bar and click cast your vote!
Previous polls: January (1 2 3 4)
Posted by Magic Academy, India at 8:28 pm
Labels: Indian magic, Indian magicians, Magic Academy, Magic in India, Magic Poll, Muthukad, Poll result
No comments:
Subscribe to: Post Comments (Atom)


text:
Saint Maughold (Macaille, Maccaldus, Machalus, Machaoi, Machella, Maghor, Mawgan, Maccul, Macc Cuill) of Man (died ca. 488 AD) is venerated as the patron saint of the Isle of Man. Tradition states that he was an Irish prince and captain of a band of thieves who was converted to Christianity by Saint Patrick.
He retired to the Isle of Man after traveling by sea, either to avoid worldly temptation, or because Patrick had punished him by placing him in a coracle without oars.
One local legend about what made Patrick punish Maughold relates how Maughold tried to make a fool out of Patrick. Maughold had, according to this story, placed a living man in a shroud. He then called for Patrick to try to revive the allegedly dead man. Patrick came, placed a hand on the shroud, and left. When Maughold and his friends opened the shroud, they found the man had died in the interim. One of Maughold's friends, a fellow named Connor, went over to Patrick's camp and apologized to him.
Patrick returned and baptized all of the men assembled. He then blessed the man who had died, who immediately returned to life, and was also baptized.
Patrick then criticized Maughold, saying he should have been helping his men into leading good lives, and told him he must make up for his evil.
Maughold drifted to this isle, where two of Patrick's disciples, Romulus and Conindrus (Romuil and Conindri), were already established.
He is said to have been chosen as bishop, succeeding Romuil and Conindri, by the Manx people after he had spent time on the island as a hermit.
He is today best remembered on the Isle of Man for his kind disposition toward the Manx natives. Several places on the island, including, Maughold parish, Maughold Head, and St. Maughold's Wellare named after him.


text:
For some reason it's something I have avoided in the past, partly because of the bewildering array of 'special' utensils listed in my recipe books - jam thermometer, jam funnel, special pans, waxed circles, preserving jars etc etc. Perusing the Lakeland website (my kitchen utensil supplier of choice ) confirmed my suspicions that these things cost money. More than I can afford to shell out for what, at best would be a once or twice yearly activity. I really might just as well go out to the supermarket and just buy a jar or two of jam (good stuff, obviously. The ones with 'extra' on the label somewhere...) So I avoided making jam.
This year, however, I thought 'Sod it! Surely I don't really need all that stuff? I mean how difficult can it be? Really?'
And you know what? It really isn't as mystical as hardcore jammers would have us believe.
There are loads of recipes on the internet but basically you need the same weight of sugar and fruit.
I had 600gms of blackberries and apples (peeled and chopped up small) from my mother-in-law's garden, so used 600gms of sugar. I added a large dash (more of a slosh really...) of lemon juice coz it seemed to be mentioned in at least three of the recipes I looked at. And a slosh of water. I have no idea how much... (sorry thats not very helpful I know, but that's the kind of cook I am )
Bring to the boil gently on the lowest heat you can - this can take quite a while so put some music on and make sure kiddiewinks are occupied. You do have to keep an eye on it and stir it so it doesnt burn/stick! In the meantime put a saucer in the freezer (one of those 'mystical' jam things - will become clear in a bit!) and place your washed jam jars upside down in a warm oven for half an hour to sterilize them (140C/275F/Gas1) If you are making this sort of quantity you will only need one or two - recycle old jam jars rather than buying special 'preserving jars'.
Once the fruit and sugar mix has come to the boil keep it there, stirring pretty much constantly for a good 10 mins or so. To test whether 'setting point' has been reached drop a small amount of the HOT jam on the ice cold saucer you have just fished out of the freezer. If its ready it should set fairly quickly as it cools. If not keep it boiling and try again in 10 mins. When ready, remove from the heat and allow to cool for 15mins then ladle into sterilsed jars.
Et Voila!
|I know it's chunky but that's the way (uh huh uh huh) I like it (uh huh uh huh)
No complicated ingredients or utensils need! (Sorry Lakeland, but rest assured I will spend my money on other lovely things...)
This is quite a small amount of jam and should keep fine in the fridge - I have no idea how long it will last - but if your house is anything like mine it will be eaten up long before it has chance to go off!